Which dosage of simvastatin in renal transplant patients?

Nephron

Volumn 84, Issue 1, 2000, Pages 81-82

  Çelik, Ali ^a,b   Ünsal, Abdülkadir ^a   Mutaf, Işil ^a   Habif, Sara ^a   Ok, Ercan ^a   Bayindir, Oya ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Ilica Mahallesi Karakizli Sokak   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLESTEROL; CYCLOSPORIN A; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; SIMVASTATIN;

CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG METABOLISM; DRUG SAFETY; FEMALE; GRAFT REJECTION; HUMAN; HYPERLIPIDEMIA; KIDNEY TRANSPLANTATION; LETTER; LIPID BLOOD LEVEL; MALE; MYALGIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RHABDOMYOLYSIS; SIDE EFFECT;

EID: 0033980026     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045544     Document Type: Letter

References (9)